Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study

Wendy C Moore1 Wake Forest School of Medicine Department of Internal Medicine, Section on Pulmonary, Critical Care, Allergy and Immunologic Diseases, Winston-Salem, NC, USACorrespondence[email protected]

https://orcid.org/0000-0001-6869-3059 View further author information

Dennis K Ledford2 Morsani College of Medicine, University of South Florida, and James A. Haley Veterans’ Hospital, Tampa, FL, USAView further author information

Donna D Carstens3 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USAView further author information

Christopher S Ambrose4 BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA

https://orcid.org/0000-0003-4175-7336 View further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date